Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
130 participants
OBSERVATIONAL
2016-02-29
2028-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PRE-DELIRIC Prediction Model Plus SMART Care to Reduce the Incidence of Delirium in ICU Patients
NCT06279390
PupillOmetry for Prediction of DelirIUM
NCT05248035
Awakening-Breathing Coordination, Delirium Monitoring/Management & Early Mobility (ABCDE) Protocol
NCT01413009
DANish DELIrium Study On Neurointensive Care Patients
NCT02594982
Mobilisation in the EveNing to TreAt Delirium
NCT05401461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Delirium group
ICU patients with a positive Confusion Assessment Method (CAM) score; observational using accelerometers, commercially available camera, and Internet Pod (iPod).
Confusion Assessment Method
Confusion Assessment Method (CAM) score
Accelerometer
3 accelerometers (placed on upper arm, wrist and ankle) and 1 placed on wall as ambient light sensor
Commercially available camera
As part of facial recognition video system
Internet Pod (iPod)
Monitors noise levels in the room
Control group
ICU patients with a negative Confusion Assessment Method (CAM) score; observational using accelerometers, commercially available camera, and Internet Pod (iPod).
Confusion Assessment Method
Confusion Assessment Method (CAM) score
Accelerometer
3 accelerometers (placed on upper arm, wrist and ankle) and 1 placed on wall as ambient light sensor
Commercially available camera
As part of facial recognition video system
Internet Pod (iPod)
Monitors noise levels in the room
Healthy control group
Healthy subjects that sleep in their home environment; observational using accelerometers, cortisol swabs, and Internet Pod (iPod)
Accelerometer
3 accelerometers (placed on upper arm, wrist and ankle) and 1 placed on wall as ambient light sensor
Internet Pod (iPod)
Monitors noise levels in the room
Cortisol Swab
Cortisol level collected through self administered salivary swab
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Confusion Assessment Method
Confusion Assessment Method (CAM) score
Accelerometer
3 accelerometers (placed on upper arm, wrist and ankle) and 1 placed on wall as ambient light sensor
Commercially available camera
As part of facial recognition video system
Internet Pod (iPod)
Monitors noise levels in the room
Cortisol Swab
Cortisol level collected through self administered salivary swab
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* 18 years of age or older.
* sleeps in home environment
Exclusion Criteria
* Less than 18 years of age
* Inability to wear a motion sensor watch (ActiGraph)
* does not sleep in home environment
* Less than 18 years of age
* Inability to wear a motion sensor watch (ActiGraph)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
U.S. National Science Foundation
FED
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
NIH
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Azra Bihorac, MD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UF Health
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.